HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

CINCINNATI (WKRC) - A new study found a correlation between regular use of a popular over the counter drug and a decreased risk in certain types of cancer. The study, published in the Journal of ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The American ...

Lantern Pharma's LP-300, targeting non-small cell lung cancer in never smokers ... The company recorded a Q4 net loss of $5.9M or $0.54 per share. For the full year, the net loss was $20.8M ...

Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients ... please refer to the Risk Factors (“Facteurs de Risque") section of ...

About Innate Pharma Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients ... looking information and risk factors This press release ...